Angiotensin 1-7: A Second Window of Protection in Hypertensive Patients

dc.contributor.authorMazin Salaheldin Abdalla Mohamed
dc.contributor.authorMuntaser Ibrahim
dc.contributor.authorMuhanad S. Abdelwhab
dc.date.accessioned2022-12-27T06:56:46Z
dc.date.available2022-12-27T06:56:46Z
dc.date.issued2019-04-18
dc.description.abstractThe effects of the renin-angiotensin-aldosterone system on the human body are so diverse and our knowledge about them is ever growing. Angiotensin 1-7 has been proven to play protective roles in patients with cardiovascular disorders including but not limited to hypertension. As is the case with Africa, the prevalence of hypertension in Sudan is rising, and its complications could be delayed by pharmacologically manipulating the levels of renin-angiotensin system metabolites. The aim of this review is to compare the advantageous and deleterious effects of Angiotensin 2 in contrast to those of Angiotensin 1-7 and to assert the well-established protective effects of Angiotensin 1-7 (systemically and locally) in hypertensive patients
dc.identifier.citationMohamed, M. S. A., Ibrahim, M., & Abdelwhab, M. S. (2019). Angiotensin 1-7: A Second Window of Protection in Hypertensive Patients. Cardiology and Angiology: An International Journal, 8(2), 1–7. https://doi.org/10.9734/ca/2019/v8i230095
dc.identifier.issn2347520X
dc.identifier.urihttp://dspace.napata.edu.sd/handle/123456789/162
dc.language.isoen
dc.titleAngiotensin 1-7: A Second Window of Protection in Hypertensive Patients
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Angiotensin 1-7 A Second Window of Protection in Hypertensive Patients.pdf
Size:
1.41 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Collections